Saint Petersburg, Florida, September 8, 2026 – Stemedix has published new educational resources that examine current research on regenerative therapy for autoimmune pain, highlighting available treatment approaches and patient safety considerations. The initiative reflects increasing public interest in evidence-based information as more individuals living with autoimmune conditions seek additional options to manage chronic pain alongside their existing medical care.
Autoimmune diseases affect an estimated 4.6% of the U.S. population, according to research led by the Mayo Clinic. With millions of Americans living with autoimmune-related pain and inflammation, the need for reliable information about available treatment options continues to grow.
Regenerative Therapy Offers a Personalized Approach for Autoimmune Pain
Unlike approaches that follow a standard treatment plan for every patient, regenerative medicine treatment is developed after reviewing each individual's diagnosis, medical history, laboratory findings, imaging, and specialist records. Because autoimmune diseases vary widely in severity and symptoms, physicians evaluate multiple factors before recommending a course of care.
Treatment Recommendations Are Based on Individual Needs
Depending on the patient's diagnosis and medical history, providers may recommend one or more regenerative medicine therapies, including:
-
Mesenchymal signaling cell (MSC) therapy
-
Platelet-rich plasma (PRP)
-
Prolozone therapy
-
Ozone IV therapy
Each option is selected based on the location of inflammation, tissue damage, overall health, and current disease activity. Existing physician records also help providers determine whether a patient may benefit from treatment or whether additional evaluation is appropriate before moving forward.
"Patients deserve access to clear, research-based information before exploring regenerative medicine treatment," said Fred Palmer, CEO of Stemedix. "Every autoimmune condition is different, which is why reviewing a patient's medical history, diagnosis, and current health status is an important part of developing an individualized treatment plan and monitoring progress over time."
Research Continues to Support the Safety Profile
Interest in regenerative medicine has increased alongside ongoing clinical research evaluating its safety and potential role in treating immune-related conditions.
A 2020 meta-analysis published in EClinicalMedicine reviewed 55 clinical studies involving 2,696 patients and found no meaningful increase in serious adverse events, including infection, thrombosis, death, or malignancy, compared with control groups. The most commonly reported treatment-related reaction was transient fever.
Additional research published in the Journal of Biomedical Science reported that 230 of approximately 500 registered clinical trials, representing about 42%, focused on immune-mediated and inflammatory diseases, including autoimmune disorders. The continued growth in clinical research reflects ongoing scientific interest in regenerative medicine and its potential applications across a range of inflammatory conditions.
Researchers have also noted that additional long-term studies will continue to build knowledge about patient outcomes, making physician evaluation and follow-up an important part of treatment planning.
Regenerative Therapy in Saint Petersburg, FL, Includes Comprehensive Patient Evaluation
Patients considering regenerative therapy in Saint Petersburg, FL, complete a structured evaluation before treatment recommendations are made. Board-certified providers review physician records, laboratory reports, imaging studies, medication history, and the current status of the patient's autoimmune condition before developing a personalized plan.
Monitoring Continues Throughout the Treatment Process
Patient monitoring extends beyond the initial appointment and may include:
-
Review of current medical records and diagnostic testing
-
Evaluation of autoimmune disease activity
-
Selection of therapies based on the patient's condition
-
Observation during treatment sessions
-
Scheduled follow-up visits to monitor pain levels, physical function, and recovery
Patients experiencing active autoimmune flare-ups, recent infections, or unstable laboratory findings may require additional review before treatment is recommended. Follow-up evaluations also allow providers to observe patient response and determine whether future treatment plans should be adjusted.
Growing Interest in Individualized Care for Autoimmune Conditions
As autoimmune disorders continue to affect millions of people, healthcare providers are placing greater emphasis on treatment strategies that consider each patient's unique medical history and current condition. Regenerative therapy has become an area of growing clinical interest because treatment plans are developed according to documented diagnoses and individual health factors rather than following a uniform approach.
Patients seeking regenerative therapy in Saint Petersburg, FL, often travel from different parts of the country. To support those visiting the practice, travel coordination services, including hotel accommodations and transportation arrangements, are available to simplify the treatment experience.
About Stemedix
Stemedix is a regenerative medicine practice based in St. Petersburg, Florida, serving patients with chronic pain, orthopedic injuries, autoimmune conditions, and degenerative disorders. Working with board-certified providers, the practice develops personalized regenerative medicine treatment plans after reviewing existing diagnoses, physician records, laboratory findings, and imaging studies. The organization also assists patients traveling from outside the region with care coordination to support their treatment visits.
Media Contact
Fred Palmer
CEO, Stemedix
Bayfront Medical Plaza 601
7th Street S. Suite 565
Florida, Saint Petersburg 33701
Phone: (727) 456-8968
Email: yourjourney@stemedix.com
Contact Page: https://stemedix.com/contact/
